CE认证
皮肤填充剂
Yvoire Y-Solution 720 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution line, indicated for severe and extreme volume loss and for correction of facial morphological asymmetry. The Y-Solution numbers are lift tiers rather than concentrations, and the 720 is the strongest lift tier in the line; the range is built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that support projection, flexibility and resistance to the movement of facial expressions, and peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks. The product contains cross-linked hyaluronic acid at 20 mg/mL (2.0%) with 0.3% lidocaine, the same composition as stated for the 540, is CE-marked and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 27G needles enclosed, with a shelf life of 17 months, shorter than the 24 months of the Classic, Volume and Contour references.
主要优势： Yvoire Y-Solution 720
- Combines high elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides projection with flexibility, designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 20 mg/mL with 0.3% lidocaine
- Built on the manufacturer's S-HICE cross-linking process
- The strongest lift tier in the Y-Solution line, indicated by the manufacturer for severe and extreme volume loss and for facial morphological asymmetry
- Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks
- Supplied with two Terumo thin-wall 27G needles
- CE-marked medical device under Notified Body 1023
适应症与专业用途
主要适应症
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring elasticity, cohesion and resistance to facial movement
专业用途
Yvoire Y-Solution 720 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 27G needles, a heavier gauge than the 29G supplied with Y-Solution 360, consistent with a more concentrated gel at 20 mg/mL. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment.
治疗部位
- Face
适用患者
Suitable for adult patients seeking anti-ageing correction with projection that holds through facial movement, as assessed by a qualified practitioner. The manufacturer's leaflet gives severe and extreme volume loss and correction of facial morphological asymmetry among its indications, making it the strongest lift tier in the Y-Solution line; patients wanting the lightest option are better served by the 360 reference. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
作用原理： Yvoire Y-Solution 720
The Yvoire 720 filler works through cross-linked hyaluronic acid at 20 mg/mL (2.0%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between high elasticity and cohesion. The intended behaviour is spring-like: the gel holds projection while still flexing with the face, which is what the Y-Solution line is positioned around rather than static filling. It is the strongest lift tier in the line, against the lightest 12 mg/mL of Y-Solution 360, and the two Terumo thin-wall 27G needles enclosed reflect the heavier body. Note that the 540 states the same 20 mg/mL composition, so the difference between those two is lift positioning rather than concentration. The 0.3% lidocaine acts locally to improve comfort during injection.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 YVOIRE 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
How does Yvoire Y-Solution 720 differ from Yvoire Y-Solution 360 and Yvoire Y-Solution 540?
Yvoire Y-Solution 360 is the lightest at 12 mg/mL with finer 29G needles. Yvoire Y-Solution 720 and Yvoire Y-Solution 540 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, so they differ in lift positioning rather than in stated composition. The Y-Solution numbers are lift tiers, not concentrations.
How long do the results of Yvoire Y-Solution 720 last?
The manufacturer publishes no duration of effect. Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks, which is the only figure with a published source behind it.
更多产品： LG Chem
诊所替代选择
美塑疗法
水光针
/ 最近浏览
继续浏览
Yvoire Y-Solution 720 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution line, indicated for severe and extreme volume loss and for correction of facial morphological asymmetry. The Y-Solution numbers are lift tiers rather than concentrations, and the 720 is the strongest lift tier in the line; the range is built on a synergy between elasticity and cohesion, giving the gel spring-like characteristics that support projection, flexibility and resistance to the movement of facial expressions, and peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks. The product contains cross-linked hyaluronic acid at 20 mg/mL (2.0%) with 0.3% lidocaine, the same composition as stated for the 540, is CE-marked and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 27G needles enclosed, with a shelf life of 17 months, shorter than the 24 months of the Classic, Volume and Contour references.
主要优势： Yvoire Y-Solution 720
- Combines high elasticity and cohesion, which the manufacturer describes as spring-like characteristics
- Provides projection with flexibility, designed to resist the dynamics of facial expression
- Cross-linked hyaluronic acid at 20 mg/mL with 0.3% lidocaine
- Built on the manufacturer's S-HICE cross-linking process
- The strongest lift tier in the Y-Solution line, indicated by the manufacturer for severe and extreme volume loss and for facial morphological asymmetry
- Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks
- Supplied with two Terumo thin-wall 27G needles
- CE-marked medical device under Notified Body 1023
适应症与专业用途
主要适应症
- Anti-ageing aesthetic treatment
- Facial projection support
- Treatments requiring elasticity, cohesion and resistance to facial movement
专业用途
Yvoire Y-Solution 720 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 27G needles, a heavier gauge than the 29G supplied with Y-Solution 360, consistent with a more concentrated gel at 20 mg/mL. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment.
治疗部位
- Face
适用患者
Suitable for adult patients seeking anti-ageing correction with projection that holds through facial movement, as assessed by a qualified practitioner. The manufacturer's leaflet gives severe and extreme volume loss and correction of facial morphological asymmetry among its indications, making it the strongest lift tier in the Y-Solution line; patients wanting the lightest option are better served by the 360 reference. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.
作用原理： Yvoire Y-Solution 720
The Yvoire 720 filler works through cross-linked hyaluronic acid at 20 mg/mL (2.0%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between high elasticity and cohesion. The intended behaviour is spring-like: the gel holds projection while still flexing with the face, which is what the Y-Solution line is positioned around rather than static filling. It is the strongest lift tier in the line, against the lightest 12 mg/mL of Y-Solution 360, and the two Terumo thin-wall 27G needles enclosed reflect the heavier body. Note that the 540 states the same 20 mg/mL composition, so the difference between those two is lift positioning rather than concentration. The 0.3% lidocaine acts locally to improve comfort during injection.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 YVOIRE 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
How does Yvoire Y-Solution 720 differ from Yvoire Y-Solution 360 and Yvoire Y-Solution 540?
Yvoire Y-Solution 360 is the lightest at 12 mg/mL with finer 29G needles. Yvoire Y-Solution 720 and Yvoire Y-Solution 540 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, so they differ in lift positioning rather than in stated composition. The Y-Solution numbers are lift tiers, not concentrations.
How long do the results of Yvoire Y-Solution 720 last?
The manufacturer publishes no duration of effect. Peer-reviewed clinical work on this reference reports aesthetic improvement sustained to around 52 weeks, which is the only figure with a published source behind it.
更多产品： LG Chem
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。